Kaposis Sarcoma-Associated Herpesvirus Transactivartor RTA Promotes - - PowerPoint PPT Presentation

kaposi s sarcoma associated herpesvirus transactivartor
SMART_READER_LITE
LIVE PREVIEW

Kaposis Sarcoma-Associated Herpesvirus Transactivartor RTA Promotes - - PowerPoint PPT Presentation

Kaposis Sarcoma-Associated Herpesvirus Transactivartor RTA Promotes Degradation of the Repressors To Regulate Viral Lytic Replication Zhilong Yang, Zhangcai Yan, and Charles wood Journal of virology, 82(7): 3590-3603, 2008 Speaker: Hsin-I


slide-1
SLIDE 1

1

Kaposi’s Sarcoma-Associated Herpesvirus Transactivartor RTA Promotes Degradation of the Repressors To Regulate Viral Lytic Replication

Zhilong Yang, Zhangcai Yan, and Charles wood

Journal of virology, 82(7): 3590-3603, 2008

Speaker: Hsin-I Tong Advisor: Li-Kwan Chang, Ph.D.

12/23/2008

slide-2
SLIDE 2

2

Kaposi’s Sarcoma

‧Tumor, caused by HHV-8/KSHV ‧One of AIDS defining illness ‧assoicated with high mortality

slide-3
SLIDE 3

3

‧Human Herpes Virus 8 (HHV-8), γherpesvirus ‧DNA Virus, linear dsDNA, with envelop ‧infect B cell, endothelial cell, monocyte, nerve cells ‧cause of Kaposi’s Sarcoma, primary effusion lymphoma,multicentric castleman’s disease (rare) Kaposi’s Sarcoma-Associated HerpesVirus (KSHV)

slide-4
SLIDE 4

4

latent/lytic switch

Immediate-early

Early

Late Transactivator Replication machinerises, kinase Glycoprotein, capsid protein

RTA

The establishment of latency Reactivation from latency lytic replication

slide-5
SLIDE 5

5

‧KSHV Immediate early protein (ORF 50) ‧ Necessary and sufficient for virus reactivation ‧ Strong/only transcription activator ‧Ubiquitine E3 ligase function

pEarly gene pEarly gene

Viral genome

RTA

Early proteins Viral reactivation, enter of the lytic replication

regulation of transcription activation

slide-6
SLIDE 6

6

RTA

Early proteins

pEarly gene pEarly gene

Viral genome

Viral reactivation, enter of the lytic replication

pEarly gene pEarly gene

Viral genome

Repressor

Virus stays in latency

Repressor

?

RTA

Viral/Cellular factors:

K-RBP, KbZIP, NF-κB , LANA

slide-7
SLIDE 7

7

KSHV RTA binding protein (K-RBP)

‧Cellular RTA binding protein ‧ transcriptional repressor

RTA

pEarly gene pORF57

Viral genome

K-RBP Virus stays in latency

slide-8
SLIDE 8

8

Objectives

‧How RTA overcome K-RBP repression?

Proposed model

slide-9
SLIDE 9

9

Framework

Proposed Model

  • RTA expression promotes K-RBP degradation
  • K-RBP degradation is mediated by the ubiquitin-

proteasome pathway

  • Correlation of RTA-mediated transactivation and

degradation

slide-10
SLIDE 10

10

RTA expression promotes K-RBP degradation

control cotransfected Western blot analysis

slide-11
SLIDE 11

11

RTA enhances KRBP turnover rate

CHX=Cycloheximide Protein synthesis inhibitor

slide-12
SLIDE 12

12

Framework

Proposed Model

  • RTA expression promotes K-RBP degradation
  • K-RBP degradation is mediated by the ubiquitin-

proteasome pathway

  • Correlation of RTA-mediated transactivation and

degradation

slide-13
SLIDE 13

13

Protein degradation pathways 1.Lysosome-dependent pathway 2.Proteasome-dependent pathway

?

slide-14
SLIDE 14

14

Early proteins

pEarly gene pORF57

Viral genome

Viral reactivation, enter of the lytic replication

RTA reduce K-RBP protein level

K-RBP

?

RTA

pEarly gene pORF57

Viral genome

Fail entering viral reactivation

RTA do not reduce K-RBP protein level

K-RBP

?

RTA

slide-15
SLIDE 15

15

Proteasome-dependent inhibitor Lysosome-dependent inhibitor RTA promotes K-RBP degradation via the proteasome-dependent pathway

slide-16
SLIDE 16

16

Ubiquitination

Ubiquitin-activating enzyme Ubiquitin-conjugating enzyme Ubiquitin-protein ligase

Proteasome-dependent degradation

slide-17
SLIDE 17

17

Immunoprecipitation (IP) protein-protein binding

K-RBP

His Ub

HA

Anti-His

Anti-HA

In Vivo ubiqutination of K-RBP (withou RTA)

Anti-KRBP

Ub

HA

Ub

HA

Ub

HA

slide-18
SLIDE 18

18

K-RBP Ubiquitination increased in the presence of RTA

In Vivo In Vitro

RTA(E3) enhance ubiquitination of K-RBP

Human E2

1 2 3 4 1 2 3 4

slide-19
SLIDE 19

19

Framework

Proposed Model

  • RTA expression promotes K-RBP degradation
  • K-RBP degradation is mediated by the ubiquitin-

proteasome pathway

  • Correlation of RTA-mediated transactivation and

degradation

slide-20
SLIDE 20

20

Framework

  • Correlation of RTA-mediated transactivation and

degradation

pEarly gene pORF57

Viral genome

Fail entering viral reactivation

K-RBP

RTA K-RBP repress RTA-mediated transactivation

U b Ub U b U b

Enter lytic replication

slide-21
SLIDE 21

21

pORF57 Luciferase

RTA

luciferase luciferase luciferase

Detection

Luciferase assay

slide-22
SLIDE 22

22

Luciferase activity represent RTA transactivation activity

slide-23
SLIDE 23

23 pEarly gene pORF57

Viral genome

RTA

RTA Transactivity set as 100% For the White bar

Luciferase gene

slide-24
SLIDE 24

24

Luciferase activity represent RTA transactivation activity

Set as 100% in each concentration

slide-25
SLIDE 25

25 pEarly gene pORF57

Viral genome

K-RBP

RTA

U b Ub U b U b

RTA transactivity partically blocked by K-RBP

RTA Transactivity Luciferase gene

slide-26
SLIDE 26

26

Luciferase activity represent RTA transactivation activity

74% 17% % inhibited by K-RBP Set as 100% in each concentration

slide-27
SLIDE 27

27

RTA wild type vs. RTA mutant (lower degradation ability)

Lower degradation ability associates with lower transactivation ability

slide-28
SLIDE 28

28

Summary

slide-29
SLIDE 29

29

Thank you Thank you

Special Thanks

  • Dr. Li-Kwan Chang